With the global economy remaining stagnant, Big Pharma companies are keen to develop blockbuster drugs that have a high financial ceiling. Rodger McMillan, VP of R&D at Astra Zeneca has said that “big pharma is a cash-rich industry – it has to be,” namely because of the huge costs in developing new drugs
24 November, 2010
London Genetics Limited and Astrimmune have entered into a collaboration to plan a biomarker identification programme for Astrimmune's early-stage pancreatic cancer vaccine candidate.
12 November, 2010
Twenty-two team members of Quantum Pharmaceutical took part in this year’s ‘Big Zip’ charity zip-wire jump last Saturday at Newcastle’s Tyne Bridge.
04 November, 2010